A whole host of new tools for the early detection of Alzheimer’s disease may be on the horizon. This week: A new blood test to help diagnose AD has gone on sale, but with a catch. Also, we bring you up to speed on a group of researchers who discovered a new blood-based biomarker for…
Psychedelics are emerging as a promising treatment for PTSD, and this week, we could be adding migraines to magic mushrooms’ list of new disease targets. It still makes sense to go with tried and true migraine therapies, though, because new research indicates one of the old standards could bring a side effect that might just…
We put a lot of hope in the neurological therapy pipeline because—let’s face it—what’s available isn’t all that great. This week, an early-stage trial brings alarming new results for a hotly-anticipated multiple sclerosis therapy that we’re all rooting for. Plus, we’ve got plenty of good eats for Parkinson’s protection, a drug that will de-chronic your…
Ever wondered if you’re really making a difference as a neurologist? Well, let go of that uncertainty right now. We’ve got the data to prove that the world desperately needs you—and will likely continue to need you for decades to come. But that’s not all. We’re also bringing you new tricks to help your patients…
All eyes are on aducanumab, the Biogen drug that has some folks leaping for joy and others scratching their heads. The Alzheimer’s needle is moving elsewhere, too—prepare for a new blood test that’s available right now in clinics across the US (if you don’t have it already), and get ready to open your mind to…
